CONMED Corporation Cash Flow Statement
CNMD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
CONMED Corporation generated $171M in operating cash flow and $151M in free cash flow in FY2025. Free cash flow margin was 11.0% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $47.1M | $132.4M | $64.5M | -$80.6M | $62.5M | $9.5M | $28.6M | $40.9M | $55.5M | $14.7M | $30.5M | $32.2M | $35.9M | $40.5M | $752.0K |
| Depreciation & Amortization | $17.1M | $16.6M | $16.2M | $16.1M | $16.5M | $18.0M | $18.7M | $18.5M | $20.1M | $20.5M | - | $19.8M | $18.7M | - | $18.5M |
| Operating Cash Flow | $170.7M | $167.0M | $125.3M | $33.4M | $111.8M | $64.5M | $95.1M | $74.7M | $65.6M | $39.9M | $50.9M | $65.2M | $80.9M | $95.2M | $103.0M |
| Capital Expenditures | $19.8M | $13.1M | $19.0M | $21.8M | $14.9M | $13.0M | $20.1M | $16.5M | $12.8M | $14.8M | $15.0M | $15.4M | $18.4M | $21.5M | $17.6M |
| Free Cash Flow | $150.9M | $153.9M | $106.3M | $11.6M | $96.9M | $51.5M | $75.1M | $58.2M | $52.7M | $25.1M | $35.9M | $49.8M | $62.5M | $73.7M | $85.4M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | $0 | $0 | $16.9M | $50.6M | $3.9M | $15.0M |
| Dividends Paid | $24.7M | $24.7M | $24.5M | $24.0M | $23.3M | $22.8M | $22.6M | $22.4M | $22.3M | $22.2M | $22.1M | $22.0M | $16.7M | $12.9M | $0 |
| FCF Margin | 11.0% | 11.8% | 8.5% | 1.1% | 9.6% | 6.0% | 7.9% | 6.8% | 6.6% | 3.3% | 5.0% | 6.7% | 8.2% | 9.6% | 11.8% |